Filana Therapeutics (FLNA) Earnings Date & Reports

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

FLNA is expected to report earnings to rise 19.05% to -25 cents per share on November 11

Filana Therapeutics FLNA Stock Earnings Reports

Q3'26

Est.

$-0.25

Q1'26

Beat

by $0.10

Q4'25

Beat

by $0.01

The last earnings report on May 07 showed earnings per share of -20 cents, beating the estimate of -31 cents. With 205.26K shares outstanding, the current market capitalization sits at 37.29M.

View a ticker or compare two or three

FLNA

Daily Signal:

Gain/Loss:

Trend Trader: Popular Stocks, 60 min, (TA&FA)Trend Trader: Popular Stocks, 60 min, (TA&FA)

VIEW DETAILS VIEW DETAILS

VIEW FOR FREE VIEW FOR FREE

Interact to see
Advertisement